PT73291B - Process for the preparation of novel peptides - Google Patents

Process for the preparation of novel peptides

Info

Publication number
PT73291B
PT73291B PT73291A PT7329181A PT73291B PT 73291 B PT73291 B PT 73291B PT 73291 A PT73291 A PT 73291A PT 7329181 A PT7329181 A PT 7329181A PT 73291 B PT73291 B PT 73291B
Authority
PT
Portugal
Prior art keywords
ser
asp
gln
tyr
thr
Prior art date
Application number
PT73291A
Other languages
English (en)
Portuguese (pt)
Other versions
PT73291A (en
Inventor
Behrend Friedrich Lundt
Karin Damm Jorgensen
Nils Langeland Johansen
Frederik Christian Gronvald
Erik Kai Frandsen
Allister James Moody
Jan Markussen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of PT73291A publication Critical patent/PT73291A/pt
Publication of PT73291B publication Critical patent/PT73291B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT73291A 1980-07-01 1981-06-30 Process for the preparation of novel peptides PT73291B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK283180A DK283180A (da) 1980-07-01 1980-07-01 Polypeptider og derivater deraf

Publications (2)

Publication Number Publication Date
PT73291A PT73291A (en) 1981-07-01
PT73291B true PT73291B (en) 1983-05-11

Family

ID=8116221

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73291A PT73291B (en) 1980-07-01 1981-06-30 Process for the preparation of novel peptides

Country Status (13)

Country Link
US (1) US4598065A (OSRAM)
EP (1) EP0044168B1 (OSRAM)
JP (1) JPS5746950A (OSRAM)
AT (1) ATE13433T1 (OSRAM)
AU (1) AU548677B2 (OSRAM)
CA (1) CA1185180A (OSRAM)
DE (1) DE3170587D1 (OSRAM)
DK (1) DK283180A (OSRAM)
FI (1) FI812044L (OSRAM)
GR (1) GR74361B (OSRAM)
NO (1) NO812233L (OSRAM)
PT (1) PT73291B (OSRAM)
ZA (1) ZA813803B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ202757A (en) * 1981-12-23 1985-11-08 Novo Industri As Peptides and medicaments
WO1983002271A1 (en) * 1981-12-28 1983-07-07 Novo Industri As Use of peptides as a medicament
DK27885A (da) * 1985-01-22 1986-07-23 Novo Industri As Fremstilling af peptider
US5120712A (en) * 1986-05-05 1992-06-09 The General Hospital Corporation Insulinotropic hormone
US5118666A (en) * 1986-05-05 1992-06-02 The General Hospital Corporation Insulinotropic hormone
US6849708B1 (en) 1986-05-05 2005-02-01 The General Hospital Corporation Insulinotropic hormone and uses thereof
EP1498425A1 (en) * 1986-05-05 2005-01-19 The General Hospital Corporation Use of glucagone-like-peptide 1 (GLP-1) derivatives for the preparation of pharmaceutical compositions
US7138486B2 (en) 1986-05-05 2006-11-21 The General Hospital Corporation Insulinotropic hormone derivatives and uses thereof
US5614492A (en) * 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
WO1990011296A1 (en) * 1989-03-20 1990-10-04 The General Hospital Corporation Insulinotropic hormone
US5238683A (en) * 1989-11-24 1993-08-24 The United States Of America As Represented By The Department Of Health And Human Services Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
US5958881A (en) * 1991-04-25 1999-09-28 Korman; Louis Y. Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
US5681816A (en) * 1992-04-24 1997-10-28 Korman; Louis Y. Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
GB9409496D0 (en) 1994-05-12 1994-06-29 London Health Ass Method for improving glycaemic control in diabetes
JP2009507050A (ja) * 2005-09-08 2009-02-19 ガストロテック・ファルマ・アクティーゼルスカブ 胆道ジスキネジーおよび／または胆道痛／不快の治療のためのｇｌｐ−１分子の使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643345C3 (de) * 1967-08-19 1975-09-25 Hoechst Ag, 6000 Frankfurt Glucagonderivat und Verfahren zur Herstellung von Glucagon
US3715345A (en) * 1970-08-03 1973-02-06 Lilly Co Eli Glucagon separation process
US3875138A (en) * 1973-09-27 1975-04-01 Lilly Co Eli Process for recovering glucagon
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
JPS5657753A (en) * 1979-10-16 1981-05-20 Toyo Jozo Co Ltd Novel glucagon fragment, and its use

Also Published As

Publication number Publication date
ATE13433T1 (de) 1985-06-15
ZA813803B (en) 1982-06-30
EP0044168B1 (en) 1985-05-22
EP0044168A1 (en) 1982-01-20
NO812233L (no) 1982-01-04
DK283180A (da) 1982-01-02
JPS5746950A (en) 1982-03-17
AU7236481A (en) 1982-01-07
US4598065A (en) 1986-07-01
PT73291A (en) 1981-07-01
FI812044L (fi) 1982-01-02
GR74361B (OSRAM) 1984-06-28
FI812044A7 (fi) 1981-01-02
AU548677B2 (en) 1986-01-02
CA1185180A (en) 1985-04-09
DE3170587D1 (en) 1985-06-27

Similar Documents

Publication Publication Date Title
PT73291A (en) Process for the preparation of novel peptides
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
EP0046590A3 (en) Phen(alk)oxy-substituted oxirane-carboxylic acids, process for their preparation, their use and drugs containing them
IL62847A0 (en) Pharmaceutical composition for the treatment of juvenile diabetes mellitus
JPS5228922A (en) Medicine mixture for animals
DE3375914D1 (en) Novel 5-membered cyclic compounds, process for the production thereof, and pharmaceutical use thereof
JPS5228946A (en) Amino acid infusion
ZA815094B (en) Novel peptide
JPS525300A (en) Display
JPS522463A (en) Structure of glass portion of deformation case
JPS5225024A (en) Tickicide
JPS5424868A (en) Novel glucagon fragment
EP0034495A3 (en) Hypoglycemic guanylamidines, processes for their preparation, and pharmaceutical compositions containing them
JPS5221286A (en) Liquid crystal composite
JPS51145407A (en) A regenerating structure
IT8367658A0 (it) Preparato farmaceutico contenente un frammento del peptide alfa endorfina
JPS5432333A (en) Covering material for optical glass fibers
JPS5239269A (en) Screw conveyor
JPS51124438A (en) Reinforced phto-fibre
JPS5377012A (en) Peptide
JPS5227766A (en) Synthesis of human gastrin i
JPS52111756A (en) Glass for wrist watch
JPS5283513A (en) Novel antibiotics fortemycin c
EP0050856A3 (en) New peptide, process for its preparation and pharmaceutical composition containing it